Pharma gets social: GlaxoSmithKline embraces facebook engagement
Posted 21st September 2011 in Articles, Commercial | Register to comment
In the first of a new series looking at pharma’s involvement in social media Daniel Ghinn discusses GSK’s involvement with facebook.
Amongst professionals in pharmaceutical companies there are mixed feelings about social media, and opinions differ as to whether it is…
Read the full articleSteps to take for higher forecasting accuracy
Posted 14th September 2011 in Articles, Commercial | Register to comment
Andree Bates offers her top tips on improving your forecasting accuracy.
Much of marketing is based on setting expectations (forecasts) and meeting these (sales achieved). Taking that a step further, the…
Read the full articlemHealth Monthly Mashup: release 3.0 – the role of non-profits in mHealth innovation
Posted 23rd August 2011 in Articles, Commercial | Register to comment
Checking in to his next instalment in the series, Michael Spitz teams with Michelle Petersen to discuss how non-profits have shaped the evolution of mHealth and continue to benefit millions throughout the world.
The notion that complex problems demand equally complex solutions is endemic throughout…
Read the full articleMedical consumer devices as product drivers in prescription drug marketing
Posted 16th August 2011 in Articles, Commercial, Devices & Diagnostics | Register to comment
Dominic Meyer and Bob Rava provide a lesson in utilising medical consumer devices as drivers of prescription drugs sales.
In Europe, where no direct to patient (DTP) marketing for prescription drugs is allowed, medical consumer devices, like injection devices…
Read the full articleHow to find hidden opportunities in your current sales accounts
Posted 10th August 2011 in Articles, Commercial | Register to comment
All too often marketing messages are based around the most obvious differentiating factor of the product rather than factors which will increase prescribing as Andree Bates highlights…
Effective salespeople can help your company stay strong. However, they must be given the
right strategies, targets, tools and processes in order to…
Emerging markets – the new gold rush? (part 2)
Posted 1st August 2011 in Articles, Commercial | 2 comments
Amit Vaidya continues with his advice on entering emerging markets.
A decision to enter emerging markets is a joined-up cross-company and cross-functional approach that could involve some or all of the…
Read the full articleEnterprise 2.0: part 4 – how do we start?
Posted 12th July 2011 in Articles, Commercial | Register to comment
In his latest piece, René van den Bos discusses the first steps towards transforming your business into social business.
‘We want to start using Twitter professionally, but how do we do that?’ ‘I want to start a Facebook group, can you help me?’ Regularly I receive these…
Read the full articlePharma on Facebook: past, present and future
Posted 8th July 2011 in Articles, Commercial | Register to comment
Upcoming changes to facebook pages will mean that comments can no longer be disabled or moderated. With the challenge this presents to pharma companies Wendy Blackburn discusses whether pharma and facebook can still be friends.
There’s been much discussion around the pharmaceutical industry’s use of social media, especially Facebook. Is it worth the risk for…
Read the full articleA beginner’s guide to digital pharma: part 10 – social bookmarking
Posted 16th June 2011 in Articles, Commercial | Register to comment
With so much on the web how do you remember the best bits and share them with your friends? This week we explore the growing importance of social bookmarking.
Welcome to the world of organising! You’ve probably all heard the term ‘social bookmarking’ – some of you will be familiar with the concept but…
Read the full articleExpert review: market access – a function or a state of mind?
Posted 13th June 2011 in Articles, Commercial | Register to comment
Kicking off our new Expert review series, Mark Waker shares his expert opinion on how market access can be incorporated into a state of mind.
Market access and its challenges have filled many column inches in recent years. Organisations like NICE have now been…
Read the full article